Transforming Global Health: Discover how the Dengue Alliance is a breakthrough treatment for millions worldwide.
Globela Pharma Private Limited
Leading Pharma Company with Strong Presence in ROW export Market. Oncology Orals, DC Granules, Tablets and Capsules .
Dengue is the most rapidly spreading mosquito-borne viral infection in the world.?
Every year, 390 million people get infected with dengue and among them 96 million people are symptomatic.?
With the rapid spreading of the high infection rate, there's a need for effective treatment and comprehensive strategies to combat this disease.?
For this, the Dengue Alliance will be launched in 2022.?
Dengue Alliance is a groundbreaking global partnership focused on delivering effective and affordable treatment for dengue patients within the next five years.?
This alliance is led by the Drugs for Neglected Diseases initiate and important institutions from dengue-endemic countries like the Faculty of Medicine at Siriraj Hospital, Thailand, the Ministry of Health, Malaysia, Transitional Health Science and Technology Institute, India, Oswaldo Cruz Foundation, Brazil, and Federal University of Minas Gerais, Brazil.?
Aim of Dengue Alliance:?
To tackle dengue with an integrated approach.?
Includes vector control vaccines
Clear therapeutic solutions against different dengue virus serotypes?
Benefits of Dengue Alliance:
If anything is going forward and having benefits, then there are also challenges.?
Some of the common challenges faced in this area:?
Join us in supporting the Dengue Alliance initiative and be a part of the change towards a dengue-free world.